NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.550
+0.160 (6.69%)
Apr 29, 2026, 9:59 AM EDT - Market open
NovaBridge Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 210.63 | 68.26 | 291.51 | 465.99 | 554.68 | Upgrade
|
| Short-Term Investments | 0.21 | 105.14 | 20.22 | 34.8 | 118.56 | Upgrade
|
| Cash & Short-Term Investments | 210.84 | 173.4 | 311.73 | 500.78 | 673.24 | Upgrade
|
| Cash Growth | 21.59% | -44.38% | -37.75% | -25.61% | -8.25% | Upgrade
|
| Accounts Receivable | - | - | - | - | 45.16 | Upgrade
|
| Other Receivables | 1.79 | 1.17 | 1.83 | 4.81 | 16 | Upgrade
|
| Receivables | 1.79 | 1.17 | 1.83 | 4.81 | 61.16 | Upgrade
|
| Inventory | - | - | - | - | 4.29 | Upgrade
|
| Prepaid Expenses | 0.7 | 1.13 | 0.12 | 1.38 | 1.41 | Upgrade
|
| Restricted Cash | - | - | - | 14.03 | - | Upgrade
|
| Other Current Assets | 4.19 | 1 | 16.23 | 4.78 | 12.62 | Upgrade
|
| Total Current Assets | 217.52 | 176.69 | 329.91 | 525.79 | 752.72 | Upgrade
|
| Property, Plant & Equipment | 2.95 | 3.8 | 5.55 | 17.97 | 24.95 | Upgrade
|
| Long-Term Investments | 37.24 | 30.82 | - | 4.47 | 55.43 | Upgrade
|
| Goodwill | - | - | - | 23.57 | 25.59 | Upgrade
|
| Other Intangible Assets | - | - | - | 17.24 | 18.84 | Upgrade
|
| Other Long-Term Assets | 2.81 | 1.37 | 33.46 | 1.58 | 4.19 | Upgrade
|
| Total Assets | 260.52 | 212.68 | 368.92 | 590.63 | 881.72 | Upgrade
|
| Accrued Expenses | 16.82 | 7.53 | 6.58 | 100.48 | 92.27 | Upgrade
|
| Short-Term Debt | - | - | - | 2.75 | - | Upgrade
|
| Current Portion of Leases | 0.89 | 0.82 | 0.63 | 3.47 | 4.83 | Upgrade
|
| Current Unearned Revenue | - | - | - | 1.26 | - | Upgrade
|
| Other Current Liabilities | 9.18 | 0.11 | 50.94 | 1.96 | 1.13 | Upgrade
|
| Total Current Liabilities | 26.89 | 8.45 | 58.14 | 109.92 | 98.23 | Upgrade
|
| Long-Term Leases | 2.18 | 3.07 | 3.26 | 4.65 | 12.87 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 38.84 | 35.26 | Upgrade
|
| Other Long-Term Liabilities | 0.51 | - | 64.93 | 15.32 | 17.61 | Upgrade
|
| Total Liabilities | 29.58 | 11.52 | 126.34 | 168.73 | 163.97 | Upgrade
|
| Common Stock | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 1,527 | 1,460 | 1,475 | 1,389 | 1,433 | Upgrade
|
| Retained Earnings | -1,332 | -1,286 | -1,264 | -994.92 | -685.52 | Upgrade
|
| Treasury Stock | -5.04 | -6.23 | -8.01 | -3.08 | - | Upgrade
|
| Comprehensive Income & Other | 41.55 | 33.38 | 39.77 | 31 | -29.36 | Upgrade
|
| Total Common Equity | 230.94 | 201.16 | 242.58 | 421.9 | 717.75 | Upgrade
|
| Shareholders' Equity | 230.94 | 201.16 | 242.58 | 421.9 | 717.75 | Upgrade
|
| Total Liabilities & Equity | 260.52 | 212.68 | 368.92 | 590.63 | 881.72 | Upgrade
|
| Total Debt | 3.07 | 3.88 | 3.89 | 10.87 | 17.7 | Upgrade
|
| Net Cash (Debt) | 207.78 | 169.52 | 307.84 | 489.91 | 655.53 | Upgrade
|
| Net Cash Growth | 22.57% | -44.93% | -37.16% | -25.26% | -10.41% | Upgrade
|
| Net Cash Per Share | 2.17 | 2.09 | 3.70 | 5.94 | 8.63 | Upgrade
|
| Filing Date Shares Outstanding | 115.65 | 81.5 | 80.7 | 82.99 | 82.55 | Upgrade
|
| Total Common Shares Outstanding | 115.38 | 81.5 | 80.7 | 82.99 | 79.92 | Upgrade
|
| Working Capital | 190.63 | 168.24 | 271.77 | 415.87 | 654.49 | Upgrade
|
| Book Value Per Share | 2.00 | 2.47 | 3.01 | 5.08 | 8.98 | Upgrade
|
| Tangible Book Value | 230.94 | 201.16 | 242.58 | 381.09 | 673.32 | Upgrade
|
| Tangible Book Value Per Share | 2.00 | 2.47 | 3.01 | 4.59 | 8.42 | Upgrade
|
| Machinery | - | - | 1.77 | 9.33 | 6.1 | Upgrade
|
| Construction In Progress | - | - | - | 0.9 | 3.32 | Upgrade
|
| Leasehold Improvements | - | - | 0.87 | 5.42 | 2.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.